Cure My Disease

Don't miss your cure!

 Log in / Sign up

Magnetic chair therapy aims to strengthen pelvic floor without surgery

NCT ID NCT07792031

Disease control Sponsor: Espacio Gaspar Clinic Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 28, 2026 · Last updated Sep 04, 2026 · Updated 1 time

Summary

This trial tests whether sitting in a special electromagnetic chair can reduce urinary incontinence episodes in women with mixed urinary incontinence, a condition combining stress and urge leaks. Half of the 58 participants will receive 12 sessions of electromagnetic chair therapy over six weeks, while the other half will receive standard electrostimulation with biofeedback. Researchers will compare the change in daily incontinence episodes from the start to week 6, with follow-up at week 30 to see if any benefits last.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Electromagnetic chair therapy (extracorporeal magnetic stimulation) compared to standard electrostimulation with biofeedback
What this could lead to
If it works, this could offer women with mixed urinary incontinence a non-invasive, drug-free alternative to standard pelvic floor therapy, potentially improving bladder control and quality of life.
What could go wrong
This is a small, early-stage trial, and the treatment may not prove as effective as standard care. Some women may not respond, and the effects may not last beyond the study period.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 58 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women ≥ 18 years of age. * Diagnosis of mixed urinary incontinence according to the operational definition. * Symptom duration ≥ 3 months. * Minimum severity: ≥ 2 total incontinence episodes documented in the baseline 3-day bladder diary up to 5 incontinence episodes * Treatment-naive: * With no pharmacologic treatment for OAB/UI in the previous 8 weeks. * With no supervised pelvic floor rehabilitation, electrical stimulation, PTNS, neuromodulation, or prior electromagnetic chair therapy (preferably never, for population homogeneity). * Ability to complete bladder diaries and questionnaires and attend scheduled visits (and all 12 treatment sessions). * Signed informed consent. Exclusion Criteria: * Active or suspected unresolved urinary tract infection (urinalysis ± culture according to local practice; first episode). * Uninvestigated macroscopic hematuria. * Advanced pelvic organ prolapse (POP-Q stage III-IV). * Pregnancy or postpartum \< 2 months. * Major neurological disease affecting bladder or urethral function.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mixed urinary incontinence are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

female stress incontinence Urinary Incontinence Urinary Incontinence, Stress

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Mixed urinary incontinence Stress urinary incontinence (SUI) Stress urinary incontinence in women Urinary incontinence Urinary incontinence (UI)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.